Anti-VLA-4 and cyclosporine synergistically prolong rat heterotopic small bowel allografts.
Tice
D G
DG
Department of Surgery, SUNY Health Science Center 13210, USA.
Bruch
D
D
Ikramuddin
S
S
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D004357:Drug Synergism; D006085:Graft Survival / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D039041:Integrin alpha4beta1; D016023:Integrins / Q000276:immunology*; D007421:Intestine, Small / Q000637:transplantation*; D007959:Lymphocyte Culture Test, Mixed; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D016201:Receptors, Lymphocyte Homing / Q000276:immunology*; D016029:Receptors, Very Late Antigen / Q000276:immunology; D013997:Time Factors; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous / Q000276:immunology*
D000906:Antibodies; D007166:Immunosuppressive Agents; D039041:Integrin alpha4beta1; D016023:Integrins; D016201:Receptors, Lymphocyte Homing; D016029:Receptors, Very Late Antigen; D016572:Cyclosporine